Therefore, since PR positivity varies by menopausal status and given the increased risk of fatal disease for premenopausal patients, we investigated whether PR intra‐tumor heterogeneity influences the long‐term risk of distant recurrence. This evidence concerns the gene PGR and neoplasm.